Microbot Medical Inc. Files 8-K on Agreements and Equity Sales
Ticker: MBOT · Form: 8-K · Filed: Oct 3, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $2.10, $1.875, $2, $896,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
Related Tickers: MBOT
TL;DR
Microbot Medical (MBOT) filed an 8-K: material agreement, equity sales, and financials. Watch closely.
AI Summary
Microbot Medical Inc. filed an 8-K on October 3, 2025, reporting on events as of September 29, 2025. The filing indicates an entry into a material definitive agreement, unregistered sales of equity securities, and includes financial statements and exhibits. The company, formerly known as Cytotherapeutics Inc./DE and StemCells Inc., is incorporated in Delaware and operates in the surgical and medical instruments sector.
Why It Matters
This 8-K filing signals significant corporate activity for Microbot Medical Inc., potentially impacting its financial structure and operational agreements.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes indicate financial distress or dilution, warranting closer examination.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- Cytotherapeutics Inc./DE (company) — Former Company Name
- StemCells Inc. (company) — Former Company Name
- September 29, 2025 (date) — Earliest event reported
- October 3, 2025 (date) — Filing Date
FAQ
What is the nature of the material definitive agreement entered into by Microbot Medical Inc. as of September 29, 2025?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in this summary.
What type of equity securities were sold unregistered by Microbot Medical Inc.?
The filing lists 'Unregistered Sales of Equity Securities' as a reported item, but the specific type and details of these securities are not elaborated upon in this summary.
What are the key financial highlights or statements included in this 8-K filing?
The filing states that 'Financial Statements and Exhibits' are included, but the specific financial data is not detailed in this summary.
When was Microbot Medical Inc. incorporated and in which state?
Microbot Medical Inc. was incorporated in Delaware, as stated in the filing.
What were Microbot Medical Inc.'s former company names?
Microbot Medical Inc. was formerly known as Cytotherapeutics Inc./DE and StemCells Inc.
Filing Stats: 889 words · 4 min read · ~3 pages · Grade level 11.1 · Accepted 2025-10-03 16:30:49
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $2.10 — Common Stock"), at an exercise price of $2.10 per share, and the Holder received 600,
- $1.875 — per share of the PA Options was between $1.875 and $2.6625, generating gross proceeds
- $2 — f the PA Options was between $1.875 and $2.6625, generating gross proceeds to the
- $896,000 — ent fees and expenses, of approximately $896,000. The shares issued upon exercise of the
Filing Documents
- form8-k.htm (8-K) — 43KB
- 0001493152-25-016866.txt ( ) — 206KB
- mbot-20250929.xsd (EX-101.SCH) — 3KB
- mbot-20250929_lab.xml (EX-101.LAB) — 33KB
- mbot-20250929_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: October 3, 2025